Arcutis Biotherapeutics Inc (NQ: ARQT )
9.770
-0.430
(-4.22%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 24, 2024
Add to My Watchlist
Headline News about Arcutis Biotherapeutics Inc
![](https://cdn.pixabay.com/photo/2017/08/26/10/47/businessman-2682712__340.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
7 Analysts Have This to Say About Arcutis Biotherapeutics
August 10, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/30/carnival-logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Analyst Ratings for Arcutis Biotherapeutics
June 28, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Arcutis Biotherapeutics: Q1 Earnings Insights
May 09, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Where Arcutis Biotherapeutics Stands With Analysts
March 29, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Arcutis Biotherapeutics's Earnings Outlook
February 27, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/735904/healthcare-lab-treatment-research-scientist-1.jpg)
![](https://investorplace.com/wp-content/uploads/2020/10/stocks-to-buy-1600.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_8938.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/05/01/global_payments_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/26/aapharma_10.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/08/aapharma_10.png?width=1200&height=800&fit=crop)
Atopic Dermatitis Player Arcutis Scoops Up DucentisBioTherapeutics
September 08, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/17/arcutis-zoryve-sidebar.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/15/arcutis-hand-image.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2022/11/Stock-emergentbiosolutions-01-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/options_image_2251.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_4194.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/09/bz-pharma_1.jpg?width=1200&height=800&fit=crop)
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
September 09, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_26089.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
September 07, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/23/bz-pharma_4.jpg?width=1200&height=800&fit=crop)
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 23, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/06/image_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/23/bz-pharma_2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/04/bz-pharma_4.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/04/image9.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.